I293 A CONCLUSIVE WORD ON THE ROLE OF CHEMOTHERAPIES IN GYNECOLOGIC MALIGNANCIES

2012 ◽  
Vol 119 ◽  
pp. S235-S235
Author(s):  
S. Pignata ◽  
S. Cecere
Keyword(s):  
Gynecologic Malignancies

The role of laparoscopy in the management of gynecologic malignancies

2000 ◽  
Vol 75 (1) ◽  
pp. 60-71 ◽  
Author(s):  
Resad Pasic ◽  
Robert D. Hilgers ◽  
Ronald L. Levine
Keyword(s):  
Gynecologic Malignancies

The role of surgery in the management of gynecologic malignancies

Cancer ◽  
1983 ◽  
Vol 51 (S12) ◽  
pp. 2480-2484 ◽  
Author(s):  
J. Taylor Wharton ◽  
Creighton L. Edwards
Keyword(s):  
Gynecologic Malignancies

The Role of Interstitial Brachytherapy in Gynecologic Malignancies. The Importance of MRI Compatible Applicators in Volume Definition and Treatment Planning

Brachytherapy ◽  
2017 ◽  
Vol 16 (3) ◽  
pp. S62-S63
Author(s):  
Silvia Rodriguez Villalba ◽  
Antonio Otal Palacin ◽  
Jose Richart Sancho ◽  
Rosa Cañon Rodriguez ◽  
Jose Perez-Calatayud ◽  
...  
Keyword(s):  
Treatment Planning ◽  
Interstitial Brachytherapy ◽  
Gynecologic Malignancies

The role of sentinel node in gynecologic malignancies

2021 ◽  
Vol 72 (6) ◽  
Author(s):  
Francesco Plotti ◽  
Roberto Angioli
Keyword(s):  
Sentinel Node ◽  
Gynecologic Malignancies

The role of human epididymis protein 4 as a biomarker in gynecologic malignancies

2019 ◽  
Vol 71 (1) ◽  
Author(s):  
Francesco Plotti ◽  
Giuseppe Scaletta ◽  
Corrado Terranova ◽  
Roberto Montera ◽  
Carlo De Cicco Nardone ◽  
...  
Keyword(s):  
Gynecologic Malignancies ◽  
Human Epididymis Protein 4 ◽  
Human Epididymis

scholarly journals Present and future role of FDG-PET/CT imaging in the management of gynecologic malignancies

2014 ◽  
Vol 32 (6) ◽  
pp. 313-323 ◽  
Author(s):  
Kazuhiro Kitajima ◽  
Yasuhiko Ebina ◽  
Kazuro Sugimura
Keyword(s):  
Fdg Pet ◽  
Ct Imaging ◽  
Gynecologic Malignancies ◽  
Future Role ◽  
Pet Ct ◽  
Fdg Pet Ct

scholarly journals The role of pemetrexed in recurrent epithelial ovarian cancer: A scoping review

2018 ◽  
Author(s):  
Michael Roche ◽  
Laura Parisi ◽  
Linda Li ◽  
Amy Knehans ◽  
Rebecca Phaeton ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Epithelial Ovarian Cancer ◽  
Malignant Pleural Mesothelioma ◽  
Scoping Review ◽  
Initial Response ◽  
Pleural Mesothelioma ◽  
Advanced Stage ◽  
Gynecologic Malignancies ◽  
New Generation

Ovarian cancer is the leading cause of mortality among gynecologic malignancies, with most cases diagnosed at an advanced stage. Despite an initial response, most develop a recurrence and subsequent resistance to standard therapies. Pemetrexed (AlimtaTM) is a new generation multi-targeted antifolate initially approved for the treatment of malignant pleural mesothelioma. In recent years, it has shown promise in the treatment of recurrent epithelial ovarian cancer. In this review, we outline the current literature and discuss the future of pemetrexed in the setting of recurrent epithelial ovarian cancer.

Sign in / Sign up

Export Citation Format

Share Document